NGeneBio 3:1 Reverse Stock Split Reduces Outstanding Shares by 66.7%, Largest Shareholder Stake Unchanged

SH Healthcare Investment No.1 Association filed a major shareholding report disclosing a change in share count due to a 3:1 reverse stock split effective June 25, 2026.
The total outstanding voting shares decreased from 26,809,750 to 8,936,583 shares, a reduction of about 66.7%, but the largest shareholder's ownership remained unchanged at 23.00%.
NGeneBio has negative equity of approximately 524 million KRW, indicating a capital impairment, and this capital reduction is seen as a defensive move to improve its financial structure.
The exercise price of stock options was adjusted from 2,065 KRW to 6,195 KRW in line with the split ratio.
[AI Summary]The 3:1 reverse stock split by NGeneBio reduces shares outstanding without issuing new equity, leaving existing ownership percentages intact. This defensive move aims to address negative equity and improve per-share metrics, but does not create immediate shareholder value. Investors should monitor the company's ability to restore profitability and future capital needs.